Locations:

Tag: aortic stenosis

21-HVI-2035428-high-deployment-SAPIEN-3_650x450

January 21, 2021/Heart, Vascular and Thoracic/Heart Valve Disease

Higher Positioning of SAPIEN 3 Valve Reduces Conduction Abnormalities and Pacemaker Requirements

Novel TAVR deployment technique improves outcomes without compromising safety

20-HVI-2018223_aortic-valve-anatomy_650x450

December 17, 2020/Heart, Vascular and Thoracic/Heart Valve Disease

Aortic Valve Replacement in Young and Middle-Aged Adults: New Data to Guide Decision-Making

Database analysis sets stage for a multicenter trial assessing TAVR’s potential role

November 19, 2020/Heart, Vascular and Thoracic/Research

Recent U.S. Progress Against Aortic Stenosis Mortality Has Not Been Uniform

Nationwide database study finds racial and regional variations

October 12, 2020/Heart, Vascular and Thoracic/Research

TAVR More Apt to Help Than Harm in CKD, PARTNER Subanalysis Shows

Findings offer reassurance, clarify understanding of cardiorenal syndrome

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 17, 2019/Heart, Vascular and Thoracic/Research

Survival After TAVR Better in Patients with Mixed Aortic Valve Disease Vs. Pure Aortic Stenosis

Cohort study provides insights on TAVR in an understudied group

May 30, 2019/Heart, Vascular and Thoracic/Research

A New Marker for Assessing Severity of Aortic Stenosis?

Study focuses on time interval between LV and aortic systolic pressure peaks

March 16, 2019/Heart, Vascular and Thoracic/Research

TAVR Yields Similar Outcomes to SAVR at 1 Year in Patients at Low Surgical Risk

PARTNER 3 and CoreValve Low Risk reveal pros and cons of both approaches

19-HRT-169-bicuspid-aortic-valve-650×450

March 11, 2019/Heart, Vascular and Thoracic/Advancing Patient Care

Bicuspid Aortic Valve with Aneurysm: Guidance for Tailoring Surgical Strategy

Pathophysiologic understanding and deep experience with BAV are invaluable

February 11, 2019/Heart, Vascular and Thoracic/Research

RAS Inhibitors After TAVR Improve 1-Year Outcomes in Retrospective Cohort Study

Surprisingly, biggest effect seen in patients with preserved LVEF

October 22, 2018/Heart, Vascular and Thoracic/Insight & Perspectives

3 Things to Keep an Eye on in Evolving TAVR Care

Expanding indications, device refinements and accessory treatments

BackPage 2 of 3Next